NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

Tribune Media Company (NYSE: TRCO)
Class Period: November 29, 2017 to July 16, 2018
Lead Plaintiff Deadline: November 13, 2018

The complaint alleges that during the class period Tribune Media Company made materially false and/or misleading statements and/or failed to disclose that: (1) Sinclair Broadcasting Group, Inc., which had agreed to merge with Tribune, was refusing to divest itself of television stations in certain markets necessary in order to secure regulatory approval; and (2) Sinclair was taking the position that it was not legally or contractually obligated to complete the identified divestitures to ensure regulatory approval.

Get additional information about the TRCO lawsuit: http://www.kleinstocklaw.com/pslra-1/tribune-media-company-loss-submission-form?wire=3

Cocrystal Pharma, Inc. (NASDAQCM: COCP)
Class Period: September 23, 2013 to September 7, 2018
Lead Plaintiff Deadline: November 19, 2018

Cocrystal Pharma, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) defendants were engaged in a pump-and-dump scheme to artificially inflate Cocrystal’s stock price; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; (3) defendants failed to abide by SEC disclosure regulations; and (4) as a result, defendants’ statements about Cocrystal’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the COCP lawsuit: http://www.kleinstocklaw.com/pslra-1/cocrystal-pharma-inc-formerly-biozone-pharmaceuticals-inc-loss-submission-form?wire=3

Alnylam Pharmaceuticals, Inc. (NASDAQGS: ALNY)
Class Period: February 15, 2018 to September 12, 2018
Lead Plaintiff Deadline: November 26, 2018

Throughout the class period, Alnylam Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and (2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times.

Get additional information about the ALNY lawsuit: http://www.kleinstocklaw.com/pslra-1/alnylam-pharmaceuticals-inc-loss-submission-form?wire=3

Chegg, Inc. (NYSE: CHGG)
Class Period: July 30, 2018 to September 25, 2018
Lead Plaintiff Deadline: November 26, 2018

Chegg, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect users’ data; (2)  the Company lacked the internal controls and procedures to detect unauthorized access to its systems and to its data; (3)  as a result, the Company would incur additional expenses and litigation risks; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the CHGG lawsuit: http://www.kleinstocklaw.com/pslra-1/chegg-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com